Elysian to launch new £250m fund in Q1 2020
Elysian Capital is expected to launch Elysian Capital III in early 2020 with a target of around £250m.
More on Funds
Elbrus holds first close on $260m for third fund – report
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Blue Horizon Ventures closes debut fund on €183m
Food-technology-focused VC was founded in 2018 and has so far made 18 investments
New Baltic fund targets €30m to back female founders
Fund targets Baltic and Nordic startups with female founders and gender-balanced executive teams
Heal Capital closes debut fund on €100m
Healthtech-focused VC sees oppprtunities in the developing European market, managing director Christian Weiß tells Unquote
Latest News
LP Profile: IMCO
Managing partner Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Elbrus holds first close on $260m for third fund – report
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Alta Life Sciences invests in Inbiomotion
Existing investors including Institut Català de Finances also take part in the financing
Korys, FPIM et al. in €12m extended series-B for Remynd
Biotech company initially raised €12m in December 2018